SARTORIUS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 227 EUR | +3.65% |
|
+6.82% | -14.34% |
| 24/04 | SARTORIUS VORZUEGE : Gets a Buy rating from Berenberg | ZD |
| 23/04 | SARTORIUS VORZUEGE : DZ Bank gives a Sell rating | ZD |
| Sales 2024 * | 3.58B 3.83B 319B | Sales 2025 * | 4.03B 4.31B 359B | Capitalization | 17.87B 19.11B 1,594B |
|---|---|---|---|---|---|
| Net income 2024 * | 209M 223M 18.64B | Net income 2025 * | 354M 379M 31.57B | EV / Sales 2024 * | 6.12 x |
| Net Debt 2024 * | 4.05B 4.33B 361B | Net Debt 2025 * | 3.79B 4.05B 338B | EV / Sales 2025 * | 5.37 x |
| P/E ratio 2024 * |
77.7
x | P/E ratio 2025 * |
52.4
x | Employees | 14,614 |
| Yield 2024 * |
0.29% | Yield 2025 * |
0.39% | Free-Float | 35.03% |
More Fundamentals
* Assessed data
More news
Latest transcript on Sartorius AG
More recommendations
More press releases
| 1 day | +3.65% | ||
| 1 week | +6.82% | ||
| Current month | -17.45% | ||
| 1 month | -18.35% | ||
| 3 months | -16.39% | ||
| 6 months | +22.84% | ||
| Current year | -14.34% |
1 week
208.00
235.00
1 month
204.00278.50
Current year
204.00290.00
1 year
181.00310.50
3 years
181.00834.00
5 years
138.50834.00
10 years
21.68834.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 01/99/01 | |
| Chief Tech/Sci/R&D Officer | 59 | 01/95/01 | |
Volker Niebel
COO | Chief Operating Officer | 67 | 01/01/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Ebsworth
BRD | Director/Board Member | 69 | 01/20/01 |
| Director/Board Member | 58 | 06/17/06 | |
Lothar Kappich
CHM | Chairman | 67 | 01/07/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 389 M€ | +6.83% | - | |
| 0.00% | 34 M€ | +6.71% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 227 | +3.65% | 2,590 |
| 25/24/25 | 219 | -3.31% | 3,212 |
| 24/24/24 | 226.5 | -1.95% | 5,792 |
| 23/24/23 | 231 | +6.70% | 11,096 |
| 22/24/22 | 216.5 | +1.88% | 13,125 |
Delayed Quote Xetra, April 26, 2024 at 09:05 pm IST
More quotes
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Calendar
16/05/2024
- Capital Markets Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
290.2
EUR
Average target price
335.8
EUR
Spread / Average Target
+15.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -46.21% | 2.65B | |
| +18.15% | 1.87B | |
| -3.12% | 1.61B | |
| +23.78% | 1.21B | |
| -10.69% | 1.02B | |
| -20.89% | 905M | |
| -18.10% | 682M | |
| -7.14% | 716M | |
| -.--% | 301M |
- Stock Market
- Equities
- SRT3 Stock
- SRT Stock
